# Delivery Order #15B10926F00000132

McKesson Delivery Order for Opioid Use Disorder Treatment Medications

**Buyer:** Federal Prison System / Bureau of Prisons

**Award Amount:** $21,484.92
**Ceiling:** $21,484.92

**Period of Performance:** Sep 01, 2025 - Sep 30, 2026

**Identifier:** 15B10926F00000132
**NAICS:** 325412

This is a delivery order under the Department of Veterans Affairs’ Pharmaceutical Prime Vendor Contract, an established government-wide pharmaceutical supply arrangement. McKesson Corporation, a major pharmaceutical distributor, will provide controlled and non-controlled medications for inmate use in medication-assisted treatment for opioid use disorder. The order covers purchasing and supplying the required medicines through multiple invoices, supporting continuity of treatment and access to essential medications. It is part of McKesson’s broader role supplying pharmaceuticals under the parent prime-vendor agreement, which began in 2020 and is scheduled to continue into 2028. The order covers a period from September 2025 through September 2026. It was placed under the existing prime-vendor contract; the provided records do not specify the competition method for this individual order. No acquisition program, subcontractors, previous order history, or original solicitation details are provided.

### Description

MCKESSON CONTRACT - ACCT 677508 - CONTROLLED AND NON-CONTROLLED MEDICATION PURCHASE FOR INMATE USE FOR OPIOID USE DISORDER TREATMENT (MAT THERAPY) - 90F MEDICATIONS/ 1060ADB -- MULTIPLE INVOICES PURCHASED FOR FY26 1-30 SEPT

[View original record](https://www.usaspending.gov/award/CONT_AWD_15B10926F00000132_1540_36W79720D0001_3600)